{
    "title": "AstraZeneca trumpets solo strength in cancer drugs, snubbing Pfizer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2838963/AstraZeneca-trumpets-standalone-strength-drug-development.html",
    "date": "2014-11-18",
    "keywords": [
        "cancer",
        "pfizer",
        "astrazeneca",
        "growth",
        "drug",
        "company",
        "soriot",
        "takeover",
        "filing",
        "date",
        "lung",
        "pill",
        "year",
        "companys",
        "revenue",
        "oncology",
        "quarter",
        "ability",
        "deal",
        "merck",
        "strength",
        "gmt",
        "november",
        "email",
        "ben",
        "hirschler",
        "jessoplondon",
        "lineup",
        "tuesday",
        "future",
        "bidthe",
        "range",
        "diseasesneil",
        "woodford",
        "shareholder",
        "invesco",
        "investment",
        "management",
        "belief",
        "update",
        "approach",
        "holdingthe",
        "work",
        "executive",
        "business",
        "marketastrazenecas",
        "heart",
        "brilinta",
        "japan",
        "half",
        "platform",
        "raft",
        "patent",
        "bolton",
        "businesswere",
        "heartburn",
        "cholesterol",
        "nexium",
        "crestor",
        "hole",
        "tillmany",
        "return",
        "consensus",
        "monthsanother",
        "meeting",
        "event",
        "pursuit",
        "option",
        "germanys",
        "kgaa",
        "monday",
        "need",
        "productssoriot",
        "readacross",
        "pfizermerck",
        "tieupwoodford",
        "chance",
        "kind",
        "firm",
        "medicine",
        "chest",
        "dealpfizer",
        "pipeline",
        "interest",
        "portfolio",
        "immunooncology",
        "combination",
        "plannedit",
        "progress",
        "azd9291",
        "approval",
        "secondhalf",
        "acceleration",
        "submission",
        "record",
        "time",
        "yearsastrazeneca",
        "race",
        "clovis",
        "drugmaker"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}